Troubled stem-cell institute finally gets new leader
California’s $3 billion stem-cell agency, which has been without a permanent leader since the end of April, has named a respected Australian scientist, Alan Trounson, as its second president.
The agency, called the California Institute for Regenerative Medicine, has been controversial from the beginning. The question is whether Trounson can finally lend some stability to the agency’s mission of supporting stem-cell science and research to find new cures to disease — one of the most ambitious efforts worldwide in this area. See story at VentureBeat LifeSciences by David Hamilton.
Next Story: Oanda gets $100M for online currency trading for masses
Previous Story: What They Like, gaming review site, raises $1.5M
About the Author, Matt Marshall
Matt launched VentureBeat in September of 2006, with the realization that no one else was covering the entrepreneurial and tech innovation scene with the velocity or depth that he was. Prior to founding VentureBeat, he covered venture capital for the San Jose Mercury News from 2001 to 2006. In 2002, Matt was awarded "Journalist of the Year" by the Northern California Society of Professional Journalists. Prior to working at the Merc, he was a correspondent for the Wall Street Journal in Bonn, Germany from 1995 to 1998, and a writer for the Washington Post in 1994. Matt holds a PhD in Government and an MA in German and European Studies from Georgetown University. In addition to VentureBeat, Matt is also the Executive Producer of DEMO, the leading launchpad event for emerging technologies.
